Compared to non-MTM HCC, the MTM subtype typically presents with larger tumor volumes, elevated serum alpha-fetoprotein (AFP) levels, and a significantly worse prognosis [7]. The gene discussed is AFP; the disease is X-linked myotubular myopathy.